相关实验视频

Updated: May 21, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

德乌克拉维西提尼布超越牛皮的扩大治疗潜力:叙述性审查

Chul-Hwan Bang¹, Chul-Jong Park², Yoon-Seob Kim²

¹Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Journal of clinical medicine

|March 17, 2025

概括

选择性TYK2抑制剂deucravacitinib通过向促炎性细胞因子有效治疗牛皮. 它的独特机制和口服提供了一个有前途的,更安全的替代方案,用于免疫介导疾病.

科学领域:

免疫学免疫学免疫学
药理学药理学是指药理学的学科.
皮肤病学皮肤病学

背景情况:

氨酸激酶2 (TYK2) 在炎症性细胞因子信号通路中至关重要.
牛皮的发病包括关键的促炎细胞因子,如IL-12,IL-23和I型干扰素.
现有的简氏激酶 (JAK) 抑制剂缺乏TYK2选择性,可能导致更广泛的免疫抑制.

研究的目的:

审查选择性TYK2抑制剂deucravacitinib的疗效和机制.
突出deucravacitinib在治疗牛皮和其他免疫媒介疾病方面的潜力.
讨论deucravacitinib与传统的JAK抑制剂和生物药物相比的优势.

主要方法:

德乌克拉维西替尼选择性地与TYK2的伪激酶域结合,从而诱导非活性构造.
这种全抑制特别针对TYK2,确保对JAK 1/2/3.3的选择性.
关于deucravacitinib的治疗应用和患者结局的最新研究的综述.

主要成果:

德乌克拉维西替尼在牛皮治疗中表现出显著的疗效.
该药物可以选择性地抑制关键的亲炎性细胞因子,这些细胞因子与免疫介导疾病有关.
研究表明,在牛皮关节炎,狼,Sjogren病和炎症性肠道疾病中可能有好处.

结论:

德乌克拉维西替尼提供了一种有针对性和选择性的方法来抑制TYK2信号传递.
它的口服提供了一个方便的替代注射生物制剂.
德乌克拉维西替尼 (deucravacitinib) 是一个有前途的治疗选择,在免疫媒介疾病中具有潜在的安全性.

关键词:

这是一种TYK2抑制剂.自身免疫性疾病自身免疫性疾病需要使用deucravacitinib.免疫媒介疾病是免疫媒介疾病.炎症性肠病是一种炎症性肠病.棕植物性 pustulosis 的疾病.牛皮是一种牛皮.牛皮关节炎牛皮关节炎系统性红血性狼 (Systemic Lupus Erythematosus) 是一种全身性狼.

更多相关视频

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

相关概念视频

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...